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case report
Corynebacterium striatum INFectING a MaLIGNaNt cUtaNeoUs LesIoN:  
tHe eMerGeNce oF aN opportUNIstIc patHoGeN
Silvana Vargas SUPERTI(1), Daniela de Souza MARTINS(1), Juliana CAIERÃO(1), Fabiana SOARES(1), Taísa PROCHNOW(1),  
Vlademir Vicente CANTARELLI(2) & Alexandre Prehn ZAVASCKI(3)
SUMMARY
We described a case of a 27-year old male patient with skin and soft tissue infection of a neoplastic lesion caused by Corynebacterium 
striatum, an organism which has been rarely described as a human pathogen. Identification was confirmed by DNA sequencing. 
Successful treatment with penicillin was achieved. The role of the C. striatum as an emerging opportunistic pathogen is discussed. 
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INTRODUCTION
Corynebacterium species are widely disseminated in the environment 
and constitute part of the normal skin and mucous membrane flora3. 
The pathogenicity potential of coryneform bacteria has for a long 
time been underestimated3. However, owing to the increasing number 
of immunocompromised patients, some corynebacteria species have 
turned clinically relevant9. Notably, C. amycolatum, C. jeikeium and C. 
urealyticum are currently recognized as important pathogens3,5,6,8-11.
Although some reports previously described C. striatum as a causative 
agent of infections specially in immunocompromised patients, its role as 
a human pathogen is poorly understood5,9,11. We described a case of C. 
striatum skin and soft tissue infection of a malignant cutaneous lesion 
and emphasized its role as an emerging opportunistic human pathogen. 
CASE REPORT
A 27-year-old male patient with a progressive ulcerative lesion which 
started two months before his hospitalization for investigation. The lesion 
had approximately 20 cm in its larger diameter at the left cervical region 
and shoulder and presented elevated erythematous irregular borders, 
with a clean base. Local edema surrounding the lesion was present. 
A non-fetid purulent secretion was present in the latter 15 days, when 
pain at the lesion was also referred. Cervical and submandibular painful 
lymph nodes were noted. Fever was sporadic (up to 38.5 oC) during the 
course of the disease. There were no other complains. Complete blood 
count was within the normal range. The patient was submitted to lymph 
node and skin lesion biopsy. Multiple fragments from distinct sites of 
the skin lesion were removed. Ziehl-Neelsen and Grocott stains were 
negative. Gram staining of the lesion fragments revealed multiple gram-
positive coryneform bacteria, some of them within polymorphonuclear 
neutrophils. The fragments were cultured aerobically on sheep blood agar 
(bioMérieux, Brazil) for 48 hours at 36 ºC. The organism grew in pure 
culture on sheep agar plate, consisting of gram-positive, catalase-positive, 
non-spore-forming, rod shaped organism. Preliminary identification 
was performed following standard procedures for Corynebacterium 
spp3. Further biochemical identification was achieved using the API 
Coryne system (bioMérieux Marcy-l’Etoile, France), according to the 
manufacturer’s instructions. The code number achieved was 2111125, 
being the isolate identified as a C. striatum/amycolatum. Genomic DNA 
was extracted from a bacterial suspension using QIAamp DNA minikit 
(QIAGEN, Germany) according to the manufacturer’s instructions, 
and then the 16S rRNA gene was amplified by PCR with the following 
primers: 8FLP (AGT.TTG.ATC.CTG.GCT.CAG) and 16S-3 (TGT.AAA.
ACG.ACG.GCC.AGT). Reactions were submitted to 35 amplification 
cycles (95 °C for 30 seg; 55 °C for 30 seg; 72 for one min) and checked 
using agarose gel electrophoresis and UV exposure. PCR products were 
submitted to direct sequencing using the BigDye terminator chemistry 
(Applied Biosystems) and the following primers: 16S-2 (TAT.TAC.CGC.
RGC.TGC.TGG) and 1096-R (GTT.GCG.CTC.GTT.GCG.GG). The 
determined sequences consisted of about 1200 nucleotides, which were 
compared with other available sequences in the DDBJ (DNA Data Bank 
of Japan) using the Blast program. The strain showed 98% of homology 
with the C. striatum sequences available in the DDBJ database and was 
clearly distinct from C. amycolatum.
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Minimum inhibitory concentrations (MICs) were determined by 
Etest (AB Biodisk Solna, Sweden) and were as follow: penicillin = 
0.06 µg/mL; cefepime = 0.5 µg/mL; erythromycin = 0.12 µg/mL; 
tetracycline = 1 µg/mL; vancomycin = 0.25 µg/mL; clindamycin = 0.25 
µg/mL and trimethoprim/sulfamethoxazole =  4/76 µg/mL. 
  The patient was treated with IV penicillin G crystalline three 
million IU each four hours during 14 days, when a significant decrease 
in purulent secretion as well as in the erythema of the borders of the 
lesion was noted.  There was no more fever after 3-day therapy. 
The lesion proved to be a T-cell lymphoma by histopathological and 
immunohistochemistry findings and the patient was further submitted to 
chemotherapy with complete resolution of the lesion.
DISCUSSION
This report showed an indolent infection of a neoplastic tissue by 
a usually human skin colonizer, C. striatum. This pathogen has been 
increasingly recognized as a human pathogen, particularly in patients 
with severe underlying diseases5,8. 
To our knowledge, this is the first case of a C. striatum infection of a 
malignant lesion. The tissue fragments collected by surgical procedure, 
the Gram staining with intracellular coryneform bacteria, and the heavy 
growth on culture were consistent with C. striatum as the etiologic agent 
of the infection.  
Although C. striatum has been described as a cause of severe 
infections such as pneumonia and meningitis, mortality rates are usually 
low5. The infection from our report was not severe; however, even mild 
skin and soft tissue infections should be considered important, since it 
may be the source of more severe infections, such as bacteremia6. 
C. striatum is usually susceptible to a wide range of antibiotics, 
particularly β-lactams7. Nevertheless, strains presenting resistance to 
multiple antibiotics have been described in nosocomial outbreaks9, 
limiting therapeutic options for treatment of infections by this organism. 
Our isolate, however, presented very low MIC values to all drugs tested, 
except for trimethoprim-sulfamethoxazole (MIC = 4/76 µg/mL).
It has been shown that the API system is an accurate and useful 
method to identify coryneform bacteria2,4, although the API Coryne is not 
able to make the differentiation between C. striatum and C. amycolatum. 
Thus, molecular analysis is required to differentiation between these 
species.
In summary, our report reinforce the role of the C. striatum as an 
emerging opportunistic pathogen, which should no longer be considered 
just as a skin colonizer in immunocompromised patients with signs and 
symptoms of infection.
RESUMO
Corynebacterium striatum infectando lesão cutânea maligna: a 
emergência de um patógeno oportunista
Descrevemos infecção de lesão neoplásica em paciente masculino de 
27 anos, envolvendo pele e partes moles, causada por Corynebacterium 
striatum, um microrganismo raramente descrito como patógeno humano. 
A identificação foi confirmada por seqüenciamento de DNA. O paciente 
foi tratado com penicilina, com sucesso. O papel do C. striatum como 
patógeno oportunista é discutido.
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